Maravai LifeSciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRVI and other ETFs, options, and stocks.

About MRVI

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. 

CEO
Bernd Brust
CEOBernd Brust
Employees
570
Employees570
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
570
Employees570

MRVI Key Statistics

Market cap
1.03B
Market cap1.03B
Price-Earnings ratio
-4.76
Price-Earnings ratio-4.76
Dividend yield
Dividend yield
Average volume
1.23M
Average volume1.23M
High today
$4.04
High today$4.04
Low today
$3.91
Low today$3.91
Open price
$3.97
Open price$3.97
Volume
623.77K
Volume623.77K
52 Week high
$6.05
52 Week high$6.05
52 Week low
$1.67
52 Week low$1.67

Stock Snapshot

With a market cap of 1.03B, Maravai LifeSciences(MRVI) trades at $3.94. The stock has a price-to-earnings ratio of -4.76.

As of 2026-01-14, Maravai LifeSciences(MRVI) stock has fluctuated between $3.91 and $4.04. The current price stands at $3.94, placing the stock +0.8% above today's low and -2.5% off the high.

The Maravai LifeSciences(MRVI)'s current trading volume is 623.77K, compared to an average daily volume of 1.23M.

During the past year, Maravai LifeSciences(MRVI) stock moved between $1.67 at its lowest and $6.05 at its peak.

During the past year, Maravai LifeSciences(MRVI) stock moved between $1.67 at its lowest and $6.05 at its peak.

Analyst ratings

55%

of 11 ratings
Buy
45.5%
Hold
54.5%
Sell
0%

People also own

Based on the portfolios of people who own MRVI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .